Penn Medicine Provider
Neurology
Sahily Reyes Esteves, MD, PhD
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology

About me

  • Instructor A of Neurology

Education and training

  • Medical School: University of Puerto Rico
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital: Has privileges to treat patients in the hospital.
  • Princeton Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Doylestown Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Reyes Esteves is a Penn Medicine physician.

Qualifications and experience

My research

Fischer D, Reyes-Esteves S, Law C, Ford A, Schwab P, Abella BS, Schneider ALC, Kumar MA Implementation of a specialized neuroprognostication consultation program and associated provider attitudes: A survey-based study , Resusc Plus, 23: 2025


Reyes-Esteves S, Singh A, Ternes K, Mendizabal A Approaching neuro-palliative care with historically minoritized groups in the United States: A literature review and actionable recommendations , J Neurol Sci, 468: 2025,123333


Perez MA, Reyes-Esteves S, Mendizabal A Racial and Ethnic Disparities in Neurological Care in the United States , Semin Neurol, 44(2): 2024 ,178-192


Reyes, S. Targeted IL-10 therapy improves outcomes in experimental intracerebral hemorrhage , Immune Modulation and Engineering Symposium, Philadelphia, PA: 2024


Majumder, A. Reyes-Esteves, S., Marcos-Contreras, O. Brenner, J Targeted IL-10 therapy improves outcomes in intracerebral hemorrhage , NanoDDS 2024, Orlando, FL: 2024


Omo-Lamai S, Nong J, Savalia K, Kelley BJ, Wu J, Esteves-Reyes S, Chase LS, Muzykantov VR, Marcos-Contreras OA, Dollé JP, Smith DH, Brenner JS Targeting of nanoparticles to the cerebral vasculature after traumatic brain injury , PLoS One, 19(6): 2024,e0297451


Reyes-Esteves S, George DK, Cucchiara B Sex differences in treatment effect in neuroprotectant trials for acute ischemic stroke: A systematic review , J Neurol Sci, 460: 2024,122992


Nong J, Glassman PM, Shuvaev VV, Reyes-Esteves S, Descamps HC, Kiseleva RY, Papp TE, Alameh MG, Tam YK, Mui BL, Omo-Lamai S, Zamora ME, Shuvaeva T, Arguiri E, Gong X, Brysgel TV, Tan AW, Woolfork AG, Weljie A, Thaiss CA, Myerson JW, Weissman D, Kasner SE, Parhiz H, Muzykantov VR, Brenner JS, Marcos-Contreras OA Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke , Mol Ther, 32(5): 2024,1344-1358


Reyes-Esteves S, Nong J, Glassman PM, Omo-Lamai S, Ohashi S, Myerson JW, Zamora ME, Ma X, Kasner SE, Sansing L, Muzykantov VR, Marcos-Contreras OA, Brenner JS Targeted drug delivery to the brain endothelium dominates over passive delivery via vascular leak in experimental intracerebral hemorrhage , J Control Release, 356: 2023 ,185-195


Reyes-Esteves S, Kumar M, Kasner SE, Witsch J Clinical Grading Scales and Neuroprognostication in Acute Brain Injury , Semin Neurol, 43(5): 2023,664-674